Insights Into the Pathophysiology of Endocannabinoid Signaling in Schizophrenia

JAMA Psychiatry. 2019 Sep 1;76(9):887-888. doi: 10.1001/jamapsychiatry.2019.0844.

Authors

David W Volk^{1

2}, David A Lewis^{1

3}

Affiliations

¹ Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.
² Veterans Integrated Service Network 4 Mental Illness Research Education and Clinical Center, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
³ Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania.

PMID: 31166594
DOI: 10.1001/jamapsychiatry.2019.0844

No abstract available

Publication types

Editorial
Comment

MeSH terms

Endocannabinoids
Humans
Psychotic Disorders*
Schizophrenia*
Signal Transduction

Substances

Endocannabinoids